Clinical Trial Update: Clinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI)

View source ↗

Summary

This update reports the completion of a clinical validation study for Immunovia's VERIFI blood biomarker test intended to detect early-stage pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Immunovia, Inc. | Conditions: Cancer of the Pancreas, Pancreatic Cancer | Status: COMPLETED